Navigation Links
FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Date:8/28/2012

is important because it shows COURAGE and angiography alone are not enough.  FAME 2 demonstrates that when deciding between OMT and interventional therapy you need to know if there is ischemia.  This will help lead to the right therapy for the right patient," commented Scott Huennekens, President & CEO of Volcano Corporation. "With the FAME 2 data in hand, and a few moments in the cath lab to perform FFR, interventional cardiologists can confidently say to their patients that PCI is the right personalized approach for them, and have the FFR value to prove it. Having the data now published in the New England Journal is a testament to the hard work of the investigators and the quality of the study design and execution."

FAME 2 showed that patients receiving PCI with proven ischemia by FFR had 66% fewer primary endpoint events including death, MI and urgent vascularization's than those patients treated with medical therapy alone (percentage of patients who had a primary endpoint event: 4.3% in the PCI group and 12.7% in the medical-therapy group; hazard ratio with PCI, 0.32; 95% confidence interval [CI], 0.19 to 0.53; P<0.001). The Registry arm also showed that patients with a negative FFR suggesting absence of ischemia did very well being treated with just medical therapy and no further intervention (primary endpoint event rate of 3.0%).

"The evidence continues to mount that using the physiology or the functional evaluation of a lesion is better than relying on angiography alone," added Joe Burnett, Executive Vice President and Physiology Business Unit Leader for Volcano. "We are all striving to improve outcomes and control costs at the same time, which means we need to make every device count. Tools available today like FFR and IVUS provide objective evidence to help make those critical decisions. Angiography guided PCI is giving way to Functional PCI to assess, guide and document each patient's unique episode of care. This is why we a
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
2. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
3. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
4. New Data from Silences Atu027 Anticancer Trial Published at ASCO
5. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
6. 1st SynCardia Total Artificial Heart Implant Performed in New England
7. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
8. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
9. Elsevier Launches New Journal: Discourse, Context and Media
10. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
11. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... , Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... pharmacy, is proud to announce Jennifer Hagerman , ... Diplomat, will take office as the president of the ... induction ceremony will take place Feb. 28, 2015, at ... held at the Renaissance Center in Detroit, ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... Survey Underscores Impact of Disease on Work Status ... today at Digestive Disease Week(R) 2007 (DDW), from,long-term ... 1,& 2) show that subjects with moderately to ... REMICADE(R),(infliximab) in the blinded phase of the trials ...
... 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA) a ... small,molecule drugs to treat severe medical conditions, ... the Phase 2b clinical,trial in metastatic melanoma ... will be presented at the annual meeting ...
Cached Medicine Technology:Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... various districts of Punjab have been transferred by the ... fuming.// ,The transfer of these doctors in all ... imposed a ban on general transfers in all departments ... Medical Services (PCMS) Association has flayed the large-scale transfer ...
... in India annually and the country stands to lose $236 ... productive working days and// treatment costs, say experts. ... patients and more than two million patients are succumbing to ... IANS. ,Trehan spoke on the eve of World ...
... recent study has shown that several Americans, to the ... asleep, and around 4.5 percent of them use some ... problems.,Dr. Nancy J. Pearson and colleagues from the National ... report in the Archives of Internal Medicine, "Most respondents ...
... The Office for the Co-ordination of Humanitarian Affairs (OCHA) ... Niger following intense flooding from heavy rains// since July. ... five regions, posing serious health risks to them. Over ... reported over the past three weeks across the region. ...
... developed by an international team of cancer immunologists ... Cancer// Research Cancer Vaccine Collaborative (CVC) successfully induced ... late-stage metastatic disease, with results indicating that the ... in some patients, according to a paper to ...
... white blood cell chemistry known to damage kidneys used ... to a federally// funded study in genetically engineered mice ... that when blood flow is cut off and then ... cells called T lymphocytes produce toxic natural chemicals that ...
Cached Medicine News:Health News:India may Lose Over $230 bn from Heart Diseases 2Health News:Sleeping Problems Often Overcome with Alternative medicine 2Health News:A Promising New Vaccination Strategy for Late-Stage Melanoma 2Health News:A Promising New Vaccination Strategy for Late-Stage Melanoma 3Health News:A Promising New Vaccination Strategy for Late-Stage Melanoma 4Health News:White Blood Cells Can Both Hurt and Help Transplanted Kidneys 2Health News:White Blood Cells Can Both Hurt and Help Transplanted Kidneys 3
... painfree therapy stimulates the spincter and ... contractions and relaxation. By use of ... surgical operations (bladder liftings) may be ... can improve unsatisfying results. DETRUSAM intravesical ...
... operated dual-channel therapy system designed for use in ... Conti also includes a programme for treating pelvic ... Conti provokes a contraction of the pelvic floor, ... need exercising. In URGE incontinence, ELPHA 4 Conti ...
... templates for brachytherapy provide ... cost-effective solution. These templates ... faces to match existing ... Medical, Siemens, etc.) for ...
... HDR disposable template is designed ... and eliminate the need for ... with premium silicone molded over ... accurate needle placement while maintaining ...
Medicine Products: